2013至2019年美国全国及州级卒中医疗保险临终关怀受益者趋势
该研究利用2013至2019年医疗保险A部分索赔数据和疾病控制与预防中心死亡率数据,分析全国及州级≥65岁医疗保险受益人中以卒中为主要诊断的临终关怀受益者比例与数量及卒中死亡率。结果显示,临终关怀受益人数从78 812增至160 884(增长104.1%),卒中从第六位常见诊断升至第三位;州级临终关怀变化与卒中死亡率显著相关(Spearman ρ=0.5;P<0.001),州级卒中死亡率解释了48.2%的方差,但超过一半的方差仍未解释,需要进一步研究。
要点
- 2013至2019年,以卒中为主要诊断的医疗保险临终关怀受益人数从78 812增至160 884(增长104.1%)。
- 卒中从2013年第六位常见临终关怀诊断升至2019年第三位,仅次于癌症和痴呆。
- 州级卒中临终关怀变化与卒中死亡率显著相关(Spearman ρ=0.5;P<0.001),卒中死亡率解释了48.2%的方差,但超过一半的方差仍未解释,需要进一步研究。
核心结论
- 2013至2019年,以卒中为主要诊断的医疗保险临终关怀受益人数增加超过一倍,卒中从第六位常见临终关怀指征升至第三位;医疗保险合格人群卒中死亡率上升解释了部分增加,但超过一半的方差仍未解释,需要进一步研究。
研究设计与样本
- 使用2013至2019年全国及州级医疗保险A部分索赔数据和疾病控制与预防中心死亡率数据,报告≥65岁医疗保险合格个体中以卒中为主要诊断的临终关怀受益者比例和数量及卒中死亡率(每10万人)。
主要发现
- 2013至2019年,以卒中为主要诊断的医疗保险临终关怀受益人数从78 812增至160 884,增长104.1%。
- 美国≥65岁个体卒中死亡人数从2013年109 602增至2019年129 193,增长17.9%。
- 2013年卒中为第六位常见医疗保险临终关怀主要诊断,2019年升至第三位,仅次于癌症和痴呆。
- 州级卒中临终关怀变化与医疗保险合格成人卒中死亡率显著相关(Spearman ρ=0.5;P<0.001)。
- 混合效应模型中,州级卒中死亡率解释了州级卒中临终关怀比例48.2%的方差。
局限性
- 超过一半的方差仍未解释,需要进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Stroke is the fifth leading cause of death in the United States, one of the leading contributors to Medicare cost, including through Medicare hospice benefits, and the rate of stroke mortality has been increasing since 2013. We hypothesized that hospice utilization among Medicare beneficiaries with stroke has increased over time and that the increase is associated with trends in stroke death rate. METHODS: Using Medicare Part A claims data and Centers for Disease Control mortality data at a national and state level from 2013 to 2019, we report the proportion and count of Medicare hospice beneficiaries with stroke as well as the stroke death rate (per 100 000) in Medicare-eligible individuals aged ≥65 years. RESULTS: From 2013 to 2019, the number of Medicare hospice beneficiaries with stroke as their primary diagnosis increased 104.1% from 78 812 to 160 884. The number of stroke deaths in the United States in individuals aged ≥65 years also increased from 109 602 in 2013 to 129 193 in 2019 (17.9% increase). In 2013, stroke was the sixth most common primary diagnosis for Medicare hospice, while in 2019 it was the third most common, surpassed only by cancer and dementia. The correlation between the change from 2013 to 2019 in state-level Medicare hospice for stroke and stroke death rate for Medicare-eligible adults was significant (Spearman ρ=0.5; P<0.001). In a mixed-effects model, the variance in the state-level proportion of Medicare hospice for stroke explained by the state-level stroke death rate was 48.2%. CONCLUSIONS: From 2013 to 2019, the number of Medicare hospice beneficiaries with a primary diagnosis of stroke more than doubled and stroke jumped from the sixth most common indication for hospice to the third most common. While increases in stroke mortality in the Medicare-eligible population accounts for some of the increase of Medicare hospice beneficiaries, over half the variance remains unexplained and requires additional research.
引用
- de Havenon A, Skolarus LE, Mac Grory B, et al. National- and State-Level Trends in Medicare Hospice Beneficiaries for Stroke During 2013 to 2019 in the United States. Stroke. 2023. PMID: 38063013. doi:10.1161/STROKEAHA.123.045021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。